Clinical trial
Efficacy of Optive Versus Systane Concomitant With Restasis (Cyclosporine A) for the Treatment of Dry Eye Symptoms
NCT00399061 is registered in ClinicalTrials.gov with Innovative Medical as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Optive Versus Systane Concomitant With Restasis (Cyclosporine A) for the Treatment of Dry Eye Symptoms
- Lead sponsor
- Innovative Medical
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2006
- Completion date
- September 30, 2008
- Enrollment
- 55 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dry eye